JW Millsop, N Fazel - Clinics in dermatology, 2016 - Elsevier
Oral candidiasis (OC) is a common fungal disease encountered in dermatology, most commonly caused by an overgrowth of Candida albicans in the mouth. Although thrush is a …
WH Miller, CE Griffin, KL Campbell - 2012 - books.google.com
Covering the diagnosis and treatment of hundreds of dermatologic conditions, Muller and Kirk's Small Animal Dermatology, 7th Edition is today's leading reference on dermatology for …
A Akpan, R Morgan - Postgraduate medical journal, 2002 - academic.oup.com
Oral candidiasis is a common opportunistic infection of the oral cavity caused by an overgrowth of Candida species, the commonest being Candida albicans. The incidence …
DJ Sheehan, CA Hitchcock… - Clinical microbiology …, 1999 - Am Soc Microbiol
Major developments in research into the azole class of antifungal agents during the 1990s have provided expanded options for the treatment of many opportunistic and endemic fungal …
AK Gupta, HC Jain, CW Lynde, P MacDonald… - Journal of the American …, 2000 - Elsevier
A prospective, multicenter study to determine the epidemiology of onychomycosis was performed in the offices of 3 dermatologists and 1 family physician in Ontario, Canada. In the …
BE Elewski - Journal of the American Academy of Dermatology, 2000 - Elsevier
During the past decade, tinea capitis has again become a major public health concern in the United States and elsewhere. Not only is there evidence of increasing incidence of the …
M Zagórska-Dziok, M Sobczak - Pharmaceutics, 2020 - mdpi.com
Hydrogels are playing an increasingly important role in medicine and pharmacy. Due to their favorable physicochemical properties, biocompatibility, and designed interaction with living …
During the past two decades invasive fungal infections have emerged as major causes of morbidity and mortality in immunocompromised patients. Several factors have contributed to …
Treatment of superficial fungal infections has come a long way. This has, in part, been through the development and evaluation of new drugs. However, utilising new strategies …